Medical therapies for intra-hepatic cholangiocarcinoma.

Vithayathil, Mathew; Bridegwater, John; Khan, Shahid A

Vithayathil, Mathew; Bridegwater, John; Khan, Shahid A.

Affiliation

Vithayathil M; Liver Unit, Division of Digestive Diseases, Imperial College London and Imperial College Healthcare NHS Trust, London, UK.
Bridegwater J; Department of Medical Oncology, UCL Cancer Institute, London, UK.
Khan SA; Liver Unit, Division of Digestive Diseases, Imperial College London and Imperial College Healthcare NHS Trust, London, UK. Electronic address: shahid.khan@imperial.ac.uk.

J Hepatol ; 75(4): 981-983, 2021 10.

Article in En | MEDLINE | ID: mdl-34215442

Subject(s)

Cholangiocarcinoma/drug therapy; Drug Therapy/trends; Immunotherapy/trends; Drug Therapy/methods; Humans; Immunotherapy/methods

Key words

Cholangiocarcinoma; Intrahepatic; Systemic therapy; Targeted

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Cholangiocarcinoma / Drug Therapy / Immunotherapy Limits: Humans Language: En Journal: J Hepatol Journal subject: GASTROENTEROLOGIA Year: 2021 Type: Article Affiliation country: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google